Efficacy and tolerability of concurrent weekly low dose cisplatin during radiation treatment of localised muscle invasive bladder transitional cell carcinoma: a report of two sequential Phase II studies from the Trans Tasman Radiation Oncology Group.

Nirdosh Kumar Gogna,John Matthews,Sandra Turner,Heidi Mameghan,Gillian Duchesne,Nigel Spry,Martin Berry,Jacqui Keller,Lee Tripcony

Efficacy and tolerability of concurrent weekly low dose cisplatin during radiation treatment of localised muscle invasive bladder transitional cell carcinoma: a report of two sequential Phase II studies from the Trans Tasman Radiation Oncology Group.

2006

Nirdosh Kumar Gogna
John Matthews
Sandra Turner
Heidi Mameghan
Gillian Duchesne
Nigel Spry
Martin Berry
Jacqui Keller
Lee Tripcony

Background and purpose: To determine the feasibility, toxicity, and clinical effectiveness of concurrent weekly cisplatin chemotherapy in conjunction with definitive radiation in the treatment of localised muscle invasive bladder cancer.

Keywords:

Phases of clinical research
Cisplatin
Bladder cancer
Oncology
Transitional cell carcinoma
Chemotherapy
Medicine
Tolerability
Toxicity
Invasive Bladder Transitional Cell Carcinoma
Internal medicine
Clinical trial
Carcinoma
Cystectomy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations